TEPROTUMUMAB

5951 reported adverse events

Drug classes: Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]

These side effects are most commonly reported by patients taking TEPROTUMUMAB:

# Side effect Count
0 MUSCLE SPASMS 1156
1 FATIGUE 822
2 TINNITUS 627
3 HYPOACUSIS 504
4 HEADACHE 499
5 DIARRHOEA 462
6 BLOOD GLUCOSE INCREASED 458
7 NAUSEA 453
8 ALOPECIA 441
9 ENDOCRINE OPHTHALMOPATHY 375
See all common reactions for TEPROTUMUMAB

TEPROTUMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEAFNESS PERMANENT 136 0.6939
1 ORBITAL DECOMPRESSION 14 0.6087
2 DYSTHYROID OPTIC NEUROPATHY 3 0.5000
3 AUTOPHONY 34 0.4533
4 ENDOCRINE OPHTHALMOPATHY 375 0.4320
5 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 31 0.3875
6 TOXIC GOITRE 21 0.3443
7 EYELID RETRACTION 30 0.3000
8 EXPOSURE KERATITIS 7 0.2333
9 EUSTACHIAN TUBE PATULOUS 9 0.2195
See all enriched reactions for TEPROTUMUMAB